Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.23 Million ≈ $-1.06 Million USD) by net assets (CN¥2.30 Billion ≈ $336.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000766 equity financing ratio to measure how much of total assets are equity-financed.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Tonghua Golden-Horse Pharmaceutical Indu (000766) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Payoneer Global Inc NASDAQ:PAYO	0.079x
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	0.009x
Xiangyang Changyuan Donggu Industry Co Ltd SHG:603950	0.022x
Inv La Constru SN:ILC	-0.023x
Aehr Test Systems NASDAQ:AEHR	-0.021x
Coface SA PA:COFA	0.013x
Proximus NV BR:PROX	0.076x
SCHOTT Pharma AG & Co. KGaA XETRA:1SXP	0.096x

Annual Cash Flow Conversion Efficiency for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Tonghua Golden-Horse Pharmaceutical Indu market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.31 Billion ≈ $338.09 Million	CN¥105.05 Million ≈ $15.37 Million	0.045x	-36.99%
2024-12-31	CN¥2.26 Billion ≈ $330.04 Million	CN¥162.75 Million ≈ $23.81 Million	0.072x	+48.32%
2023-12-31	CN¥2.32 Billion ≈ $339.21 Million	CN¥112.78 Million ≈ $16.50 Million	0.049x	-41.85%
2022-12-31	CN¥2.37 Billion ≈ $346.59 Million	CN¥198.16 Million ≈ $29.00 Million	0.084x	+41.49%
2021-12-31	CN¥2.34 Billion ≈ $342.31 Million	CN¥138.33 Million ≈ $20.24 Million	0.059x	+68.91%
2020-12-31	CN¥2.31 Billion ≈ $337.34 Million	CN¥80.71 Million ≈ $11.81 Million	0.035x	+24.67%
2019-12-31	CN¥2.67 Billion ≈ $390.12 Million	CN¥74.86 Million ≈ $10.95 Million	0.028x	-22.55%
2018-12-31	CN¥4.71 Billion ≈ $689.06 Million	CN¥170.72 Million ≈ $24.98 Million	0.036x	+506.01%
2017-12-31	CN¥4.42 Billion ≈ $646.57 Million	CN¥26.43 Million ≈ $3.87 Million	0.006x	-72.53%
2016-12-31	CN¥4.16 Billion ≈ $608.95 Million	CN¥90.63 Million ≈ $13.26 Million	0.022x	+130.40%
2015-12-31	CN¥2.25 Billion ≈ $328.72 Million	CN¥-160.95 Million ≈ $-23.55 Million	-0.072x	-237.69%
2014-12-31	CN¥659.50 Million ≈ $96.51 Million	CN¥34.32 Million ≈ $5.02 Million	0.052x	-68.91%
2013-12-31	CN¥615.08 Million ≈ $90.01 Million	CN¥102.96 Million ≈ $15.07 Million	0.167x	+1697.12%
2012-12-31	CN¥619.60 Million ≈ $90.67 Million	CN¥-6.49 Million ≈ $-950.31K	-0.010x	+19.78%
2011-12-31	CN¥607.13 Million ≈ $88.84 Million	CN¥-7.93 Million ≈ $-1.16 Million	-0.013x	-126.80%
2010-12-31	CN¥595.89 Million ≈ $87.20 Million	CN¥29.05 Million ≈ $4.25 Million	0.049x	-64.39%
2009-12-31	CN¥583.87 Million ≈ $85.44 Million	CN¥79.94 Million ≈ $11.70 Million	0.137x	+639.34%
2008-12-31	CN¥554.08 Million ≈ $81.08 Million	CN¥10.26 Million ≈ $1.50 Million	0.019x	-0.09%
2007-12-31	CN¥536.90 Million ≈ $78.57 Million	CN¥9.95 Million ≈ $1.46 Million	0.019x	+153.30%
2006-12-31	CN¥518.07 Million ≈ $75.81 Million	CN¥-18.02 Million ≈ $-2.64 Million	-0.035x	-104.40%
2005-12-31	CN¥45.26 Million ≈ $6.62 Million	CN¥35.74 Million ≈ $5.23 Million	0.790x	+51.26%
2004-12-31	CN¥36.64 Million ≈ $5.36 Million	CN¥19.12 Million ≈ $2.80 Million	0.522x	+68.00%
2003-12-31	CN¥296.07 Million ≈ $43.32 Million	CN¥91.99 Million ≈ $13.46 Million	0.311x	+109.74%
2002-12-31	CN¥490.79 Million ≈ $71.82 Million	CN¥72.70 Million ≈ $10.64 Million	0.148x	+109.51%
2001-12-31	CN¥475.05 Million ≈ $69.52 Million	CN¥-740.34 Million ≈ $-108.34 Million	-1.558x	-955.58%
2000-12-31	CN¥1.08 Billion ≈ $157.58 Million	CN¥196.15 Million ≈ $28.70 Million	0.182x	+336.55%
1999-12-31	CN¥1.05 Billion ≈ $153.20 Million	CN¥-80.62 Million ≈ $-11.80 Million	-0.077x	+22.07%
1998-12-31	CN¥636.82 Million ≈ $93.19 Million	CN¥-62.93 Million ≈ $-9.21 Million	-0.099x	--

About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

SHE:000766 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.40 Billion

CN¥16.38 Billion CNY

Market Cap Rank

#5498 Global

#978 in China

Share Price

CN¥16.95

Change (1 day)

+2.42%

52-Week Range

CN¥15.05 - CN¥29.50

All Time High

CN¥29.50